REGISTROS MAIS RECENTES

Preprint

Os dados são atualizados diariamente a partir das seguintes fontes: 

medrxiv.org

biorxiv.org

arxiv.org

www.ssrn.com/index.cfm/en/

https://preprints.scielo.org/index.php/scielo

Busque por termos

Selecione ao lado o filtro desejado:

Últimos registros

Abaixo os últimos 30 registros encontrados em nossa base de dados.

Digite um termo acima para filtrar sua busca na tabela abaixo.

Repositório Título Autores Data URL
medrxivA Wastewater-Based Epidemic Model for SARS-CoV-2 with Application to Three Canadian CitiesShokoofeh Nourbakhsh, ...2021-07-25
medrxivPrevention and Control of Acute Respiratory Viral Infections in Adult Population: A Systematic Review and Meta-Analysis on Ginseng-Based Clinical Trials.Frank Adusei-Mensah, ...2021-07-25
medrxivProton pump inhibitor use is not associated with severe COVID-19 related outcomes: A propensity score weighted analysis of a national veteran cohortShailja C. Shah, ...2021-07-25
medrxivSafety and Immunogenicity of Nanocovax, a SARS-CoV-2 Recombinant Spike Protein VaccineThuy P Nguyen, ...2021-07-25
medrxivChallenges to self-isolation among contacts of cases of COVID-19: a national telephone survey in WalesKate Rebecca Isherwood, ...2021-07-25
medrxivWillingness to receive vaccination against COVID-19: results from a large nationally representative Australian population surveySharon R Davis, ...2021-07-25
medrxivA cross-sectional study of socioeconomic status and sickness presenteeism in Japanese workers during the COVID-19 pandemicMasashi Masuda, ...2021-07-25
medrxivKnowledge, attitude, and practices towards COVID-19 among the Rohingya refugees in Coxs Bazar, Bangladesh.Md. Fahad Jubayer, ...2021-07-25
medrxivA Multi-Site Analysis of the Prevalence of Food Security in the United States, before and during the COVID-19 PandemicMeredith T. Niles, ...2021-07-25
medrxivA spatio-temporal study of state-wide case-fatality risks during the first wave of the COVID-19 pandemic in MexicoRicardo Ramírez-Aldana, ...2021-07-25
medrxivA cluster randomised trial of the impact of a policy of daily testing for contacts of COVID-19 cases on attendance and COVID-19 transmission in English secondary schools and collegesBernadette C Young, ...2021-07-25
medrxivAntiviral metabolite 3'-Deoxy-3',4'-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19Ravi Mehta, ...2021-07-25
medrxivCharacterization of SARS-CoV-2 Genetic Material in WastewaterCarolyn A Robinson, ...2021-07-25
medrxivShocked-relaxed-tired: Mental health during the three waves of the Covid-19Jan Sebastian Novotny, ...2021-07-25
medrxivImpact of SARS-CoV-2 variant on the severity of maternal infection and perinatal outcomes: Data from the UK Obstetric Surveillance System national cohort.Nicola Vousden, ...2021-07-25
medrxivUse of Indomethacin for mild and moderate Covid -19 patients. A Randomized Control Trialravichandran rajan, ...2021-07-25
medrxivMental Health of HBCU College Students during the COVID-19 PandemicSharron Xuanren Wang, ...2021-07-25
medrxivProxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)Flavio A Cadegiani, ...2021-07-25
medrxivThe mystery of COVID-19 reinfections: A global systematic review and meta-analysis of 577 casesRubaid Azhar Dhillon, ...2021-07-24
medrxivSeverity of SARS-CoV-2 reinfections in second wave determines likelihood of mild endemicityJennie S Lavine, ...2021-07-24
medrxivOff-season RSV epidemics in Australia after easing of COVID-19 restrictionsJohn-Sebastian Eden, ...2021-07-24
medrxivComparison of infected and vaccinated transplant recipients highlights the role of Tfh and neutralizing IgG in COVID-19 protectionXavier Charmetant, ...2021-07-24
medrxivChange in Symptoms and Immune Response in People with Post-Acute Sequelae of SARS-Cov-2 Infection (PASC) After SARS-Cov-2 VaccinationDaisy Massey, ...2021-07-24
medrxivProfiling lockdown adherence and poor coping responses towards the COVID-19 crisis in an international cross-sectional surveySylvia Carina Van Belle, ...2021-07-24
medrxivVariant-driven multi-wave pattern of COVID-19 via Machine Learning clustering of spike protein mutationsAdele de Hoffer, ...2021-07-24
medrxivEthnic disparities in incident SARS-CoV-2 infections became wider during the second wave of SARS-CoV-2 in Amsterdam, the Netherlands: a population-based longitudinal studyLiza Coyer, ...2021-07-24
medrxivHigh-throughput Mutational Surveillance of the SARS-CoV-2 Spike GeneEzgi Özkan, ...2021-07-24
medrxivProteomic and metabolomic signatures associated with the immune response in healthy individuals immunized with an inactivated SARS-CoV-2 vaccineYi Wang, ...2021-07-24
medrxivDexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial- The COVID STEROID 2 trial investigators, ...2021-07-24
medrxivHospitalization Data Supports Correlation of Lower Covid-19 Severity vs. Universal BCG Immunization in the Early Phase of the PandemicSerge Dolgikh2021-07-24
Acompanhe conosco outras fontes importantes sobre covid-19 do Brasil
https://covid.saude.gov.br/

Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde. Diariamente, o Ministério da Saúde, por meio da Secretaria de Vigilância em Saúde (SVS/MS) divulga dados consolidados sobre o COVID-19. Saiba mais sobre o painel.

https://bigdata-covid19.icict.fiocruz.br/

Este projeto utiliza recursos computacionais e cientistas de dados da Plataforma de Ciência de Dados aplicada à Saúde do Laboratório de Informação em Saúde do Icict da Fiocruz (PCDaS), hospedada no Laboratório Nacional de Computação Científica (LNCC).

Campus Sede:

Av. Brasil, 4365 – Manguinhos, Rio de Janeiro – CEP: 21040-900 – Tel: (0xx21) 2598-4242

Este portal é regido pela Política de Acesso Aberto ao Conhecimento, que busca garantir à sociedade o acesso gratuito, público e aberto ao conteúdo integral de toda obra intelectual produzida pela Fiocruz.

© COPYRIGHT / Todos os direitos reservados ao Laboratório de Informação Científica e Tecnológica em Saúde – LICTS / FIOCRUZ